{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:08:38Z","timestamp":1786982918782,"version":"build-2736575974"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Inogen Inc."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pulm Ther"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s41030-024-00259-x","type":"journal-article","created":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T03:01:54Z","timestamp":1717210914000},"page":"237-262","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Health and Economic Impact of Different Long-Term Oxygen Therapeutic Strategies in Patients with Chronic Respiratory Failure: A French Nationwide Health Claims Database (SNDS) Study"],"prefix":"10.1007","volume":"10","author":[{"given":"Stanislav","family":"Glezer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregoire","family":"Mercier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Coursier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoleta","family":"Petrica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Pini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijith","family":"Pg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,1]]},"reference":[{"key":"259_CR1","unstructured":"Disease GIfCOL: GOLD 2023 - Global Strategy for Prevention, Diagnosis and Management of COPD: 2023 Report. 2023. https:\/\/goldcopd.org\/2023-gold-report-2\/"},{"key":"259_CR2","doi-asserted-by":"publisher","first-page":"734","DOI":"10.4187\/respcare.06312","volume":"63","author":"RD Branson","year":"2018","unstructured":"Branson RD. Oxygen therapy in COPD. Respir Care. 2018;63:734\u201348. https:\/\/doi.org\/10.4187\/respcare.06312.","journal-title":"Respir Care"},{"key":"259_CR3","volume-title":"StatPearls","author":"VS Mirabile","year":"2023","unstructured":"Mirabile VS, Shebl E, Sankari A, Burns B. Respiratory failure. In: StatPearls. Treasure Island: StatPearls; 2023."},{"key":"259_CR4","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1183\/09031936.00133805","volume":"28","author":"DD Sin","year":"2006","unstructured":"Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: role of comorbidities. Eur Respir J. 2006;28:1245\u201357. https:\/\/doi.org\/10.1183\/09031936.00133805.","journal-title":"Eur Respir J"},{"key":"259_CR5","first-page":"46","volume":"102","author":"A Duck","year":"2006","unstructured":"Duck A. Cost-effectiveness and efficacy in long-term oxygen therapy. Nurs Times. 2006;102:46\u201350.","journal-title":"Nurs Times"},{"key":"259_CR6","first-page":"97","volume":"15","author":"Y Oba","year":"2009","unstructured":"Oba Y. Cost-effectiveness of long-term oxygen therapy for chronic obstructive disease. Am J Manag Care. 2009;15:97\u2013104.","journal-title":"Am J Manag Care"},{"issue":"PA1053","key":"259_CR7","first-page":"2015","volume":"46","author":"NPP Kyuchukov","year":"2015","unstructured":"Kyuchukov NPP, Glogovska P, et al. Hospital treatment costs of exacerbations in COPD patients with indications for LTOT. Eur Respir J. 2015;46(PA1053):2015.","journal-title":"Eur Respir J"},{"key":"259_CR8","unstructured":"NCT03174210. Effects of supplemental oxygen delivered by a portable oxygen concentrator compared to a liquid oxygen device in COPD. 2018."},{"key":"259_CR9","unstructured":"NCT00875719: Oxygen portable concentrator during exercises in patients with COPD. 2011."},{"key":"259_CR10","unstructured":"NCT04107493: Evaluation of a portable oxygen concentrator during ambulation for patients who require supplemental oxygen (POC-LEAN). 2021."},{"key":"259_CR11","unstructured":"NCT04299178. Usability evaluation of a portable oxygen concentrator. 2020."},{"key":"259_CR12","unstructured":"NCT01673685. Trial of portable oxygen cylinders versus battery powered portable oxygen concentrators. 2017."},{"key":"259_CR13","doi-asserted-by":"publisher","first-page":"i1","DOI":"10.1136\/thoraxjnl-2015-206865","volume":"70","author":"MAJ Hardinge","year":"2015","unstructured":"Hardinge MAJ, Bourne S, et al. British Thoracic Society, BTS Home Oxygen Guideline Group: BTS guidelines for home oxygen use in adults. Thorax. 2015;70:i1\u201343.","journal-title":"Thorax"},{"key":"259_CR14","doi-asserted-by":"publisher","first-page":"e121","DOI":"10.1164\/rccm.202009-203608ST","volume":"202","author":"SS Jacobs","year":"2020","unstructured":"Jacobs SS, Krishnan JA, Lederer DJ, et al. Home oxygen therapy for adults with chronic lung disease. An official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2020;202:e121\u201341. https:\/\/doi.org\/10.1164\/rccm.202009-203608ST.","journal-title":"Am J Respir Crit Care Med"},{"key":"259_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40248-40015-40013-40244","volume":"10","author":"RW Dal Negro","year":"2015","unstructured":"Dal Negro RW, Bonadiman L, Bricolo FP, Tognella S, Turco P. Cognitive dysfunction in severe chronic obstructive pulmonary disease (COPD) with or without long-term oxygen therapy (LTOT). Multidiscip Respir Med. 2015;10:17. https:\/\/doi.org\/10.1186\/s40248-40015-40013-40244.","journal-title":"Multidiscip Respir Med"},{"key":"259_CR16","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s41030-41023-00221-41033","volume":"9","author":"R Sami","year":"2023","unstructured":"Sami R, Savari MA, Mansourian M, Ghazavi R, Meamar R. Effect of long-term oxygen therapy on reducing rehospitalization of patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Pulm Ther. 2023;9:255\u201370. https:\/\/doi.org\/10.1007\/s41030-41023-00221-41033.","journal-title":"Pulm Ther"},{"key":"259_CR17","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1136\/thx.2010.137661","volume":"66","author":"MD Eisner","year":"2011","unstructured":"Eisner MD, Iribarren C, Blanc PD, et al. Development of disability in chronic obstructive pulmonary disease: beyond lung function. Thorax. 2011;66:108\u201314. https:\/\/doi.org\/10.1136\/thx.2010.137661.","journal-title":"Thorax"},{"key":"259_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0229404","volume":"15","author":"DA Djibo","year":"2020","unstructured":"Djibo DA, Goldstein J, Ford JG. Prevalence of disability among adults with chronic obstructive pulmonary disease, Behavioral Risk Factor Surveillance System\u00a02016\u20132017. PLoS ONE. 2020;15:e0229404. https:\/\/doi.org\/10.1371\/journal.pone.0229404.","journal-title":"PLoS ONE"},{"key":"259_CR19","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.3390\/s20041178","volume":"20","author":"D Sanchez-Morillo","year":"2020","unstructured":"Sanchez-Morillo D, Mu\u00f1oz-Zara P, Lara-Do\u00f1a A, Leon-Jimenez A. Automated home oxygen delivery for patients with COPD and respiratory failure: a new approach. Sensors (Basel). 2020;20:1178.","journal-title":"Sensors (Basel)"},{"key":"259_CR20","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1513\/AnnalsATS.202005-202487OC","volume":"18","author":"J Dakkak","year":"2021","unstructured":"Dakkak J, Tang W, Smith JT, et al. Burden and unmet needs with portable oxygen in patients on long-term oxygen therapy. Ann Am Thorac Soc. 2021;18:1498\u2013505. https:\/\/doi.org\/10.1513\/AnnalsATS.202005-202487OC.","journal-title":"Ann Am Thorac Soc"},{"key":"259_CR21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4187\/respcare.07829","volume":"66","author":"P Moretta","year":"2021","unstructured":"Moretta P, Molino A, Martucci M, et al. Subject preferences and psychological implications of portable oxygen concentrator versus compressed oxygen cylinder in chronic lung disease. Respir Care. 2021;66:33\u201340. https:\/\/doi.org\/10.4187\/respcare.07829.","journal-title":"Respir Care"},{"key":"259_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare8020182","author":"S M\u00f6ller","year":"2020","unstructured":"M\u00f6ller S, Ivarsson B, Nordstr\u00f6m L, Johansson A. LTOT patients\u2019 experience of a portable oxygen unit and health-related quality of life-a cross-sectional study. Healthcare (Basel). 2020. https:\/\/doi.org\/10.3390\/healthcare8020182.","journal-title":"Healthcare (Basel)"},{"key":"259_CR23","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1080\/17512433.17512018.11421457","volume":"11","author":"AS Melani","year":"2018","unstructured":"Melani AS, Sestini P, Rottoli P. Home oxygen therapy: re-thinking the role of devices. Expert Rev Clin Pharmacol. 2018;11:279\u201389. https:\/\/doi.org\/10.1080\/17512433.17512018.11421457.","journal-title":"Expert Rev Clin Pharmacol"},{"key":"259_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0152618","volume":"11","author":"J Foo","year":"2016","unstructured":"Foo J, Landis SH, Maskell J, et al. Continuing to confront COPD international patient survey: economic impact of COPD in 12 countries. PLoS ONE. 2016;11:e0152618. https:\/\/doi.org\/10.1371\/journal.pone.0152618.","journal-title":"PLoS ONE"},{"key":"259_CR25","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s40273-40015-40252-40274","volume":"33","author":"K Srivastava","year":"2015","unstructured":"Srivastava K, Thakur D, Sharma S, Punekar YS. Systematic review of humanistic and economic burden of symptomatic chronic obstructive pulmonary disease. Pharmacoeconomics. 2015;33:467\u201388. https:\/\/doi.org\/10.1007\/s40273-40015-40252-40274.","journal-title":"Pharmacoeconomics"},{"key":"259_CR26","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1513\/AnnalsATS.201601-201007ST","volume":"13","author":"KC Wilson","year":"2016","unstructured":"Wilson KC, Gould MK, Krishnan JA, et al. An official American Thoracic Society Workshop Report. A framework for addressing multimorbidity in clinical practice guidelines for pulmonary disease, critical illness, and sleep disorders. Ann Am Thorac Soc. 2016;13:S12\u201321. https:\/\/doi.org\/10.1513\/AnnalsATS.201601-201007ST.","journal-title":"Ann Am Thorac Soc"},{"key":"259_CR27","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1093\/gerona\/glx1121","volume":"73","author":"B Olaya","year":"2018","unstructured":"Olaya B, Moneta MV, Dom\u00e9nech-Abella J, et al. Mobility difficulties, physical activity, and all-cause mortality risk in a nationally representative sample of older adults. J Gerontol A Biol Sci Med Sci. 2018;73:1272\u20139. https:\/\/doi.org\/10.1093\/gerona\/glx1121.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"259_CR28","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1513\/AnnalsATS.201809-627WS","volume":"15","author":"SS Jacobs","year":"2018","unstructured":"Jacobs SS, Lederer DJ, Garvey CM, et al. Optimizing home oxygen therapy. An official American Thoracic Society Workshop Report. Ann Am Thorac Soc. 2018;15:1369\u201381.","journal-title":"Ann Am Thorac Soc"},{"key":"259_CR29","unstructured":"SNDS. Composantes du Syst\u00e8me National des Donn\u00e9es de Sant\u00e9. https:\/\/www.snds.gouv.fr\/SNDS\/Accueil. Accessed 1 Jan 2023."},{"issue":"Suppl 4","key":"259_CR30","doi-asserted-by":"publisher","first-page":"S149","DOI":"10.1016\/j.respe.2017.05.004","volume":"65","author":"P Tuppin","year":"2017","unstructured":"Tuppin P, Rudant J, Constantinou P, et al. Value of a national administrative database to guide public decisions: from the syst\u00e8me national d\u2019information interr\u00e9gimes de l\u2019Assurance Maladie (SNIIRAM) to the syst\u00e8me national des donn\u00e9es de sant\u00e9 (SNDS) in France. Rev Epidemiol Sante Publique. 2017;65(Suppl 4):S149-s167.","journal-title":"Rev Epidemiol Sante Publique"},{"key":"259_CR31","doi-asserted-by":"publisher","DOI":"10.12968\/jowc.12023.12932.Sup12969a.clxxi","author":"M Lartigau","year":"2023","unstructured":"Lartigau M, Barateau M, Ros\u00e9 M, Petric\u00e3 N, Salles N. Pressure ulcer prevention devices in the management of older patients at risk after hospital discharge: an SNDS study. J Wound Care. 2023. https:\/\/doi.org\/10.12968\/jowc.12023.12932.Sup12969a.clxxi.","journal-title":"J Wound Care"},{"key":"259_CR32","unstructured":"CNIL: Syst\u00e8me National des Donn\u00e9es de Sant\u00e9. https:\/\/www.cnil.fr\/fr\/snds-systeme-national-des-donnees-de-sante. 2021. Accessed 1 Jan 2023."},{"key":"259_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040297","volume":"4","author":"JP Vandenbroucke","year":"2007","unstructured":"Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. PLoS Med. 2007;4:e297. https:\/\/doi.org\/10.1371\/journal.pmed.0040297.","journal-title":"PLoS Med"},{"key":"259_CR34","unstructured":"Dispositifs medicaux inscrits a la liste des produits et prestations - LPP https:\/\/www.ameli.fr\/val-de-marne\/medecin\/exercice-liberal\/facturation-remuneration\/consultations-actes\/nomenclatures-codage\/liste-produits-prestations-lpp. Accessed 1 Jan 2023."},{"key":"259_CR35","unstructured":"Therapy HAdS-Aoho: Oxyg\u00e9noth\u00e9rapie \u00e0 long terme: choisir la source la mieux adapt\u00e9e. 2012. Haute Autorit\u00e9 de Sant\u00e9 - Assessment of home oxygen therapy"},{"key":"259_CR36","unstructured":"Cartographie des pathologies et des d\u00e9penses de l\u2019Assurance Maladie. https:\/\/assurance-maladie.ameli.fr\/etudes-et-donnees\/par-theme\/pathologies\/cartographie-assurance-maladie. Accessed 1 Jan 2023."},{"key":"259_CR37","doi-asserted-by":"publisher","first-page":"afab126","DOI":"10.1093\/ageing\/afab126","volume":"51","author":"T Gilbert","year":"2022","unstructured":"Gilbert T, Cordier Q, Polazzi S, et al. External validation of the Hospital Frailty Risk Score in France. Age Ageing. 2022;51:afab126.","journal-title":"Age Ageing"},{"key":"259_CR38","unstructured":"La France et ses territoires https:\/\/www.insee.fr\/fr\/statistiques\/5039991?sommaire=5040030. Accessed 1 Jan 2023."},{"key":"259_CR39","unstructured":"R\u00e9partition de l\u2019indice de d\u00e9favorisation sociale FDep15 \u00e0 l\u2019\u00e9chelle communale https:\/\/geo.data.gouv.fr\/fr\/datasets\/4db7e21edb3c4c0aef6e2149d9988b15f7d4fdb5. Accessed 1 Jan 2023."},{"key":"259_CR40","unstructured":"OM\u00e9DIT-Obeservatoire des M\u00e9dicaments Dispositifs m\u00e9dicaux Innovations Th\u00e9rapeutiques. Forfaits hebdomadaires relatifs \u00e0 l\u2019oxyg\u00e9noth\u00e9rapie - Guide to good practice and proper use of oxygenotherapy. 2018."},{"key":"259_CR41","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1177\/0962280220983512","volume":"30","author":"Y Li","year":"2021","unstructured":"Li Y, Li L. Propensity score analysis methods with balancing constraints: a Monte Carlo study. Stat Methods Med Res. 2021;30:1119\u201342. https:\/\/doi.org\/10.1177\/0962280220983512.","journal-title":"Stat Methods Med Res"},{"key":"259_CR42","unstructured":"NICE: The guidelines manual 2012. https:\/\/www.nice.org.uk\/process\/pmg6\/chapter\/assessing-cost-effectiveness."},{"key":"259_CR43","unstructured":"Facteurs d\u2019\u00e9volution des s\u00e9jours hospitaliers MCO. https:\/\/assurance-maladie.ameli.fr\/etudes-et-donnees\/2014-facteurs-evolution-sejours-hospitaliers-mco. Accessed 1 Jan 2023."},{"key":"259_CR44","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s12931-12022-02191-12937","volume":"23","author":"MJ Divo","year":"2022","unstructured":"Divo MJ, Marin JM, Casanova C, et al. Comorbidities and mortality risk in adults younger than 50\u00a0years of age with chronic obstructive pulmonary disease. Respir Res. 2022;23:267. https:\/\/doi.org\/10.1186\/s12931-12022-02191-12937.","journal-title":"Respir Res"},{"key":"259_CR45","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s11739-11020-02412-11731","volume":"16","author":"C Argano","year":"2021","unstructured":"Argano C, Scichilone N, Natoli G, et al. Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry. Intern Emerg Med. 2021;16:389\u2013400. https:\/\/doi.org\/10.1007\/s11739-11020-02412-11731.","journal-title":"Intern Emerg Med"},{"key":"259_CR46","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12931-12018-10827-12937","volume":"19","author":"PR Burgel","year":"2018","unstructured":"Burgel PR, Laurendeau C, Raherison C, Fuhrman C, Roche N. An attempt at modeling COPD epidemiological trends in France. Respir Res. 2018;19:130. https:\/\/doi.org\/10.1186\/s12931-12018-10827-12937.","journal-title":"Respir Res"},{"key":"259_CR47","doi-asserted-by":"publisher","first-page":"A4","DOI":"10.1016\/j.rmr.2016.1010.1014","volume":"34","author":"C Raherison-Semjen","year":"2017","unstructured":"Raherison-Semjen C, Ouaalaya H, Bernady A, et al. Profils de comorbidit\u00e9s et s\u00e9v\u00e9rit\u00e9 de la BPCO: donn\u00e9es de la cohorte PALOMB. Rev Mal Respir. 2017;34:A4\u20135. https:\/\/doi.org\/10.1016\/j.rmr.2016.1010.1014.","journal-title":"Rev Mal Respir"},{"key":"259_CR48","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1111\/resp.13083","volume":"22","author":"YH Khor","year":"2017","unstructured":"Khor YH, McDonald CF, Hazard A, et al. Portable oxygen concentrators versus oxygen cylinder during walking in interstitial lung disease: a randomized crossover trial. Respirology. 2017;22:1598\u2013603. https:\/\/doi.org\/10.1111\/resp.13083.","journal-title":"Respirology"},{"key":"259_CR49","doi-asserted-by":"publisher","first-page":"175346662311867","DOI":"10.1177\/17534666231186732","volume":"17","author":"S Hun Kim","year":"2023","unstructured":"Hun Kim S, Beom Shin Y, Shin MJ, et al. Effects of walking with a portable oxygen concentrator on muscle oxygenation while performing normal or pursed-lip breathing in patients with interstitial lung disease: a randomized crossover trial. Ther Adv Respir Dis. 2023;17:17534666231186732. https:\/\/doi.org\/10.1177\/17534666231186732.","journal-title":"Ther Adv Respir Dis"},{"key":"259_CR50","doi-asserted-by":"publisher","DOI":"10.1093\/ptj\/pzad1044","author":"SL Wootton","year":"2023","unstructured":"Wootton SL, Dale MT, Alison JA, et al. Mobile Health pulmonary rehabilitation compared to a center-based program for cost-effectiveness and effects on exercise capacity, health status, and quality of life in people with chronic obstructive pulmonary disease: a protocol for a randomized controlled trial. Phys Ther. 2023. https:\/\/doi.org\/10.1093\/ptj\/pzad1044.","journal-title":"Phys Ther"},{"key":"259_CR51","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.23100212-23122022","author":"S Pimenta","year":"2023","unstructured":"Pimenta S, Hansen H, Demeyer H, Slevin P, Cruz J. Role of digital health in pulmonary rehabilitation and beyond: shaping the future. ERJ Open Res. 2023. https:\/\/doi.org\/10.1183\/23120541.23100212-23122022.","journal-title":"ERJ Open Res"},{"key":"259_CR52","doi-asserted-by":"publisher","first-page":"439","DOI":"10.2147\/copd.S234942","volume":"15","author":"I Iheanacho","year":"2020","unstructured":"Iheanacho I, Zhang S, King D, Rizzo M, Ismaila AS. Economic burden of chronic obstructive pulmonary disease (COPD): a systematic literature review. Int J Chron Obstruct Pulmon Dis. 2020;15:439\u201360. https:\/\/doi.org\/10.2147\/copd.S234942.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"259_CR53","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1164\/rccm.202202-200294OC","volume":"207","author":"KI Duan","year":"2023","unstructured":"Duan KI, Birger M, Au DH, Spece LJ, Feemster LC, Dieleman JL. Health care spending on respiratory diseases in the United States, 1996\u20132016. Am J Respir Crit Care Med. 2023;207:183\u201392. https:\/\/doi.org\/10.1164\/rccm.202202-200294OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"259_CR54","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.rmr.2014.1010.1731","volume":"32","author":"C Laurendeau","year":"2015","unstructured":"Laurendeau C, Chouaid C, Roche N, Terrioux P, Gourmelen J, Detournay B. Management and costs of chronic pulmonary obstructive disease in France in 2011. Rev Mal Respir. 2015;32:682\u201391. https:\/\/doi.org\/10.1016\/j.rmr.2014.1010.1731.","journal-title":"Rev Mal Respir"},{"issue":"Suppl C","key":"259_CR55","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/s0954-6111(1003)80020-80023","volume":"97","author":"EF Wouters","year":"2003","unstructured":"Wouters EF. Economic analysis of the confronting COPD survey: an overview of results. Respir Med. 2003;97(Suppl C):S3-14. https:\/\/doi.org\/10.1016\/s0954-6111(1003)80020-80023.","journal-title":"Respir Med"}],"updated-by":[{"DOI":"10.1007\/s41030-024-00266-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T00:00:00Z","timestamp":1721174400000}}],"container-title":["Pulmonary Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41030-024-00259-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s41030-024-00259-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41030-024-00259-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T02:07:08Z","timestamp":1722046028000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s41030-024-00259-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["259"],"URL":"https:\/\/doi.org\/10.1007\/s41030-024-00259-x","relation":{},"ISSN":["2364-1754","2364-1746"],"issn-type":[{"value":"2364-1754","type":"print"},{"value":"2364-1746","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"13 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s41030-024-00266-y","URL":"https:\/\/doi.org\/10.1007\/s41030-024-00266-y","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was sponsored and funded by Inogen Inc., which has neither participated in the conduct of the study nor in the analysis of the data. At the time of study conduct and manuscript submission, Dr. Stanislav Glezer was an employee at Inogen Inc. and a shareholder of Inogen Inc. He worked as the Executive Vice President, R&D and Chief Medical Officer. Dr. Abhijith Pg is an employee at Inogen Inc. and a shareholder of Inogen Inc. He works as Director Medical Affairs. Dr. Gregoire Mercier served as French medical expert. He works as the Head of Data Science at the Montpellier University Hospital and the Desbrest Institute of Epidemiology and Public Health (IDESP), Montpellier, France. Dr. Jean-Marc Coursier served as French medical expert. He works as a pneumologist at the Antony private hospital, Antony, France. Nicoleta Petrica served as consultant data scientist, Alira Health, Paris, France. Maria Pini served as medical writer, Alira Health, Paris, France.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"In accordance with French regulations, the study protocol was approved by the ethics and scientific committee for health research, studies, and evaluations (CESREES) and by the French data privacy committee (CNIL; Decision DR-2021-228). Data access was delivered by CNAM after agreement. In the study personal data processing is intended for a research project not involving human subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}